1[1]Nobori T, Miura K, Wu DJ et al. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature, 1994,368:753
2[2]Jonatham M, Horowi Z, Park SH et al. Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells. Proc Natl Acad Sci USA, 1990,87:2775
3[3]Herman JG, Merlo A, Mao L et al. Inactivation of the CDKN2/p16/ MTS1 gene is frequently associated wth aberrant DNA methylation in all common human cancer. Cancer Res, 1995,4525
6Hong YS, Rob MS. Hypermethylation of p16 (INK4a) in Korean non-small cell lung cancer patients[J]. J Korean Med Sci, 2007,22(9) :32 -37.
7Bacher U, Haferlach T, Schoch C. Gain of 9p due to an unbalanced rearrangement der(9;18 ) :a recurrent clonal abnormality in chronic myeloproliferative disorders[ J ]. Cancer Genet Cytogenet,2005,160 (2) : 179 - 183.
8Sanki A, Li W, Colman M, et al. Reduced expression of p16 and p27 is correlated with turnout progression in cutaneous melanoma[J]. Pathology, 2007,39 ( 6 ) :551 - 557.
9Kamb A,Cruis NA, Weaver - feldhaus J, et al. A cell cycle regulator potentially involved in genesis of many tumortypes [ J ]. Science, 1994,264:436 - 440.
10[2]Weber GF,Bronson RT,Lagan J,et al.Absence of the CD44gene prevents sarcoma metastasis[J].Cancer Res,2002,62 (8):2281-2286
